. Purified Recombinant Cas9 proteins 1.2 µg of purified recombinant wt, U N , and U C Cas9 proteins were analyzed by SDS-PAGE and stained with GelCode Blue Stain Reagent. Proteins were purified from IPTG-induced cultures as follows: Cells were harvested by centrifugation, and the pellet was resuspended in 100 ml lysis buffer containing 0.5 M NaCl, 20 mM Tris-HCl, pH 8, 20 mM imidazole supplemented with 0.2mg/ml lysozyme, 20µg/ml DNase, 1mM MgCl 2 , and protease inhibitor cocktail (Calbiochem set 3), and 20mM imidazole. After lysis by protein disrupter (Constant Systems), the soluble fraction was obtained by centrifugation and purified by immobilized metal ion affinity chromatography (IMAC) using a HiTrap FF_5ml cartridge (GE Healthcare) using an FPLC system (ÄKTA GE Healthcare Life Sciences). Cas9 variants were eluted in one step with the binding buffer supplemented with 0.5M Imidazole and injected directly into a size exclusion column (HiLoad_16/60 Superdex 200) equilibrated with 20mM Tris 8, 200mM KCl and 10mM MgCl 2 . All peak fractions were analyzed for the presence of Cas9 using SDS-PAGE, and the purity was estimated to be >90%. To obtain higher purity, the pooled fractions were diluted with 20mM HEPES pH=7.5, 100mM KCl and applied to a cation exchange column (Tricorn MonoS 10/30 GL, GE Healthcare) equilibrated with the dilution buffer. The protein was eluted with the same buffer using a gradient to 1M KCl. The final pure enzyme was concentrated and supplemented with 50% glycerol and stored at -20 o C. Genomic DNA from naive HEK293 cells, and from purified single-cell clones (2A and 2B) were subjected to PCR using the primers indicated. The 600 gen forward and reverse primers generate a 600bp fragment using naive genomic template, and a 1500bp fragment with the YFP insertion. Using the YFP reverse primer and 600 gen forward primer, the expected fragment is 1050 bp. This analysis suggests biallelic insertion of the YFP cassette in the two clones, since the genomic primers no longer generate the 600 bp fragment, and only the 1500 bp fragment is detected clearly. PCR was performed on genomic DNA using the primers indicated. The (blue) genomicspecific primers generate a 580bp fragment with the naive HEK293 template, and a 2kb fragment with the proper insertion of the cassette. Using the genomic forward primer and puro (red) reverse primer, the expected fragment is 380bp. B.Puromycin-selected pools of edited cells express YFP-p73. Samples of the cells from the experiment presented in Figure 3H were replated two days post-transfection in medium with 0.5µg/ml puromycin. Control cells (transfected without Cas9) were also plated without puromycin. The control cells did not survive puromycin treatment, and thus the control sample is from cells not treated with puromycin. Cells were analyzed by SDS-PAGE and immunoblotting, with the Living Colors antibody used to detect YFP-p73. All of the puromycin-selected cells express YFP-p73. HEK293 cells were transfected with the indicated constructs and treated as described in Fig. 1C . The U N and U C constructs have the 126aa UL12 domain fused to the N-and Ctermini of Cas9, respectively. The U Ns and U Cs have the 50-126 aa domain fused to the N-and C-termini of Cas9, and U NLS has the 1-50 aa domain fused to N-terminus of Cas9. In the IP panels for Mre11, Nbs1 and Rad50, the indicated proteins, and crossreacting bands, are indicated with arrows. GATCACTAATACGACTCACTATAGgTA GAATCCCAGGATTCAGGC Supplementary Table S2 . FACS analysis of PSMB6-YFP edited cells. Raw data of the FACS experiments summarized in Figure 3C . HEK293 cells were transfected with the Cas9 constructs shown and the PSMB6-YFP donor plasmid. The percentages of YFP-positive cells from three independent experiments is shown. Supplementary Table S3 . XTT assay for quantification of puromycin-resistant cells. Raw XTT readings from experiment described in Figure 3H . Following transfection with the Cas9/sgRNA and donor plasmids, duplicate samples of cells were replated with and without puromycin, with serial dilutions. The XTT assay was used to quantify cell number. Values for the puromycin-resistant cells were normalized for number of cells plated by dividing by the value obtained for those cells grown without puromycin. The XTT values for cells grown in puromycin were in the same range as the XTT values for the 1:10 diluted cells grown without puromycin. This indicates that overall, the editing efficiency was in the range of 10%. 
